Company intelligence / Profile preview

Soteria Biotech

Xizhi District, New Taipei City, Taiwansoteriabio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Soteria Biotech has developed and commercialized a cloud-based medical software product, "Soteria One Point Zero," which assists clinicians in diagnosing and treating Obstructive Sleep Apnea Syndrome. The technology leverages advanced simulation to analyze upper airway structure/function, aiming to improve diagnostic accuracy and patient outcomes. The company holds patents in Taiwan, China, the USA, and Singapore.

Therapeutic areas: Pulmonology
Modalities: DeviceSoftware
Industry: Digital Health Medical Devices

Partnerships

Collaborations with Chang Gung Memorial Hospital Sleep Center & China Medical University Sleep Center during R&D phase

Beyond the preview

Go deeper on Soteria Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soteria Biotech.

Explore the full profile